Skip to Content

Join the 'Sonidegib' group to help and get support from people like you.

Sonidegib News

Do Rising Cancer Drug Prices Warrant Regulation?

Posted 1 Nov 2017 by Drugs.com

WEDNESDAY, Nov. 1, 2017 – Cancer drug prices in the United States keep rising steadily, a new study says. "Regardless of competition or supplemental indications, our study found that there is a steady increase in costs of patented anticancer drugs over time," wrote the researchers. They included Dan Greenberg, an associate professor at Ben-Gurion University of the Negev in Israel. "We believe ...

Many Cancer Patients Skimp on Treatment Due to Cost

Posted 24 Oct 2017 by Drugs.com

TUESDAY, Oct. 24, 2017 – The high cost of cancer care in the United States has led more than one-quarter of patients to cut back on some part of their treatment, a new survey reveals. Commissioned by the American Society of Clinical Oncology (ASCO), the report found that 27 percent of cancer survivors or close relatives of a cancer patient said they'd skipped doctor visits or taken other steps ...

Alternative Medicine Alone as Cancer Treatment Linked to Lowered Survival

Posted 17 Aug 2017 by Drugs.com

THURSDAY, Aug. 17, 2017 – People who choose alternative medicine over traditional cancer treatments for curable cancers have a higher risk of dying early, researchers report. "We now have evidence to suggest that using alternative medicine in place of proven cancer therapies results in worse survival," said study lead author Dr. Skyler Johnson from Yale School of Medicine and Yale Cancer Center. ...

Treatment Costs Can Be Another Blow to Cancer Patients

Posted 27 Jul 2017 by Drugs.com

THURSDAY, July 27, 2017 – The emotional and physical costs of cancer can be staggering. But the financial side of cancer is also a great burden, with many patients in the United States struggling to pay for treatment, new research reveals. "The current health law has greatly improved access to meaningful health coverage for cancer patients, survivors and all those with chronic diseases," Chris ...

Publicly Funded Cancer Trials Gained Americans 3 Million More Years

Posted 6 Jun 2017 by Drugs.com

TUESDAY, June 6, 2017 – Public-funded trials have significantly extended the lives of people diagnosed with cancer, according to new research. SWOG, the clinical trials network funded by the U.S. National Cancer Institute (NCI), has involved more than 200,000 patient volunteers. These trials have led to approval of 14 new cancer drugs and more than 100 changes to cancer care standards. All told, ...

U.S. Pays Highest Prices for Cancer Meds: Study

Posted 6 Jun 2016 by Drugs.com

MONDAY, June 6, 2016 – The United States pays the highest prices in the world for generic and brand-name cancer drugs, a new study has found. However, as the world's wealthiest nation, the United States is better able to pay for those pricey drugs than poorer countries with somewhat lower medication prices, added study lead author Dr. Daniel Goldstein. People in China and India are much less ...

FDA Approves Odomzo (sonidegib) for Locally Advanced Basal Cell Carcinoma

Posted 26 Jul 2015 by Drugs.com

July 24, 2015 – The U.S. Food and Drug Administration today approved Odomzo (sonidegib) to treat patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation therapy, or who are not candidates for surgery or radiation therapy. Skin cancer is the most common cancer and basal cell carcinoma accounts for approximately 80 percent of non-melanoma skin cancers. ...

New Skin Cancer Drug Odomzo Approved by FDA

Posted 26 Jul 2015 by Drugs.com

FRIDAY, July 24, 2015 – A new drug to treat the most common form of skin cancer has been approved by the U.S. Food and Drug Administration. Odomzo (sonidegib) was cleared to treat locally advanced basal cell carcinoma in patients who cannot undergo surgery or radiation therapy, or whose skin cancer has returned after surgery or radiation therapy. Skin cancer is the most common type of cancer, ...

Odomzo Approved for Recurring Basal Cell Carcinoma

Posted 26 Jul 2015 by Drugs.com

FRIDAY, July 24, 2015 – Odomzo (sonidegib) has been approved by the U.S. Food and Drug Administration to treat basal cell carcinoma skin cancer that has returned despite surgery or radiation. The treatment is sanctioned for people who are not candidates for additional surgery or radiation. Basal cell carcinoma accounts for about 80 percent of skin cancers that are not melanoma, a more deadly ...

Ask a Question

Further Information

Related Condition Support Groups

Basal Cell Carcinoma

Related Drug Support Groups

Odomzo

Sonidegib Patient Information at Drugs.com